• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食、氧化应激与代谢功能障碍相关脂肪性肝病:一篇综述短文

Diet, oxidative stress and MAFLD: a mini review.

作者信息

Hu Zenan, Yue Hanxun, Jiang Na, Qiao Liang

机构信息

The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.

Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.

出版信息

Front Nutr. 2025 Mar 4;12:1539578. doi: 10.3389/fnut.2025.1539578. eCollection 2025.

DOI:10.3389/fnut.2025.1539578
PMID:40104813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11913703/
Abstract

Globally, metabolic dysfunction-associated fatty liver disease (MAFLD), also known as non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), is a common chronic liver disease. The progression of MAFLD leads to a vicious cycle in which oxidative stress results from the disease that is augmenting de-novo lipid levels and increases steatosis. Most non-enzymatic antioxidants are present in food. Therefore, the present review summarizes the findings of studies on food-derived antioxidants and presents an oxidative stress-related regulatory network in MAFLD, offering new ideas for MAFLD prevention and treatment.

摘要

在全球范围内,代谢功能障碍相关脂肪性肝病(MAFLD),也称为非酒精性脂肪性肝病(NAFLD)或代谢功能障碍相关脂肪性肝病(MASLD),是一种常见的慢性肝病。MAFLD的进展会导致恶性循环,即该疾病引发氧化应激,进而增加从头合成脂质水平并加剧脂肪变性。大多数非酶抗氧化剂存在于食物中。因此,本综述总结了关于食物来源抗氧化剂的研究结果,并提出了MAFLD中与氧化应激相关的调控网络,为MAFLD的预防和治疗提供了新思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8882/11913703/da2217219524/fnut-12-1539578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8882/11913703/da2217219524/fnut-12-1539578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8882/11913703/da2217219524/fnut-12-1539578-g001.jpg

相似文献

1
Diet, oxidative stress and MAFLD: a mini review.饮食、氧化应激与代谢功能障碍相关脂肪性肝病:一篇综述短文
Front Nutr. 2025 Mar 4;12:1539578. doi: 10.3389/fnut.2025.1539578. eCollection 2025.
2
Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis.循环血管生成素样蛋白8(ANGPTL8)与代谢功能障碍相关的脂肪性肝病:最新系统评价与荟萃分析
Front Endocrinol (Lausanne). 2025 Apr 10;16:1574842. doi: 10.3389/fendo.2025.1574842. eCollection 2025.
3
Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.慢性肾脏病发生时代谢功能障碍相关脂肪/脂肪变性肝病的严重程度和缓解情况。
J Am Heart Assoc. 2024 Mar 5;13(5):e032604. doi: 10.1161/JAHA.123.032604. Epub 2024 Feb 23.
4
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD.代谢相关脂肪性肝病时代非侵入性评分和血清生物标志物在脂肪性肝病中的应用:从非酒精性脂肪性肝病到代谢相关脂肪性肝病和脂肪性肝病的综合评价。
Curr Obes Rep. 2024 Sep;13(3):510-531. doi: 10.1007/s13679-024-00574-z. Epub 2024 May 29.
5
Comparative application of MAFLD and MASLD diagnostic criteria on NAFLD patients: insights from a single-center cohort.MAFLD和MASLD诊断标准在非酒精性脂肪性肝病患者中的比较应用:来自单中心队列的见解
Clin Exp Med. 2025 Jan 14;25(1):36. doi: 10.1007/s10238-024-01553-3.
6
Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction.根据 MRI 衍生质子密度脂肪分数在健康检查中命名法的变化,非酒精性脂肪性肝病、代谢相关脂肪性肝病和代谢相关脂肪性肝炎的患病率存在差异。
Abdom Radiol (NY). 2024 Sep;49(9):3036-3044. doi: 10.1007/s00261-024-04285-w. Epub 2024 Apr 8.
7
Comparison of NAFLD, MAFLD, and MASLD Prevalence and Clinical Characteristics in Asia Adults.亚洲成年人中NAFLD、MAFLD和MASLD的患病率及临床特征比较
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102420. doi: 10.1016/j.jceh.2024.102420. Epub 2024 Oct 8.
8
Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease.与代谢相关的脂肪性肝病相比,代谢相关脂肪性肝病遗漏的高危患者较少。
Clin Exp Hepatol. 2024 Dec;10(4):249-256. doi: 10.5114/ceh.2024.145429. Epub 2024 Dec 2.
9
Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians.代谢相关脂肪性肝病命名对脂肪性肝病患病率和筛查的影响:亚洲前瞻性人群调查。
J Gastroenterol Hepatol. 2024 Aug;39(8):1636-1647. doi: 10.1111/jgh.16554. Epub 2024 May 2.
10
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.代谢功能障碍相关脂肪性肝病在 2 型糖尿病中的作用:韩国糖尿病协会脂肪肝研究组的综述和立场声明。
Diabetes Metab J. 2024 Nov;48(6):1015-1028. doi: 10.4093/dmj.2024.0541. Epub 2024 Nov 21.

引用本文的文献

1
Cinnamic Acid: A Shield Against High-Fat-Diet-Induced Liver Injury-Exploring Nrf2's Protective Mechanisms.肉桂酸:抵御高脂饮食诱导的肝损伤——探索Nrf2的保护机制
Int J Mol Sci. 2025 Aug 17;26(16):7940. doi: 10.3390/ijms26167940.
2
Hydrogen gas (H) delivered by intraperitoneal injection alleviated methionine- and choline-deficient diet-induced metabolic dysfunction-associated steatotic liver disease in mice via inhibiting GSDMD- and GSDME-mediated pyroptosis.腹腔注射氢气(H₂)通过抑制GSDMD和GSDME介导的细胞焦亡,减轻了蛋氨酸和胆碱缺乏饮食诱导的小鼠代谢功能障碍相关脂肪性肝病。
Front Pharmacol. 2025 Aug 8;16:1575106. doi: 10.3389/fphar.2025.1575106. eCollection 2025.
3

本文引用的文献

1
Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway.原儿茶酸通过调节 NRF2 信号通路缓解肝脂肪变性和脂肪毒性中的铁死亡。
Cell Biol Toxicol. 2024 Nov 26;40(1):104. doi: 10.1007/s10565-024-09953-7.
2
Co-occurring MASLD and Diabetes Is Associated With Increased Incidence of Cardiovascular Events and Mortality.同时存在的代谢功能障碍相关脂肪性肝病(MASLD)和糖尿病与心血管事件及死亡率的发生率增加相关。
Gastroenterology. 2024 Sep;167(4):812-813. doi: 10.1053/j.gastro.2024.04.021. Epub 2024 Apr 25.
3
Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK/SREBP1 pathway.
Association between the composite dietary antioxidant index and cardiovascular-kidney-metabolic syndrome among U.S. adults: evidence from NHANES 2007-2018.
美国成年人复合膳食抗氧化指数与心血管-肾脏-代谢综合征之间的关联:来自2007 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Front Nutr. 2025 Jul 10;12:1600651. doi: 10.3389/fnut.2025.1600651. eCollection 2025.
4
Therapeutic Efficacy of Silymarin, Vitamin E, and Essential Phospholipid Combination Therapy on Hepatic Steatosis, Fibrosis, and Metabolic Parameters in MASLD Patients: A Prospective Clinical Study.水飞蓟素、维生素E和必需磷脂联合治疗对非酒精性脂肪性肝病患者肝脂肪变性、纤维化及代谢参数的疗效:一项前瞻性临床研究
Int J Mol Sci. 2025 Jun 6;26(12):5427. doi: 10.3390/ijms26125427.
5
In Vivo Neuroprotective Effects of Alpinetin Against Experimental Ischemic Stroke Damage Through Antioxidant and Anti-Inflammatory Mechanisms.山柰酚通过抗氧化和抗炎机制对实验性缺血性脑卒中损伤的体内神经保护作用
Int J Mol Sci. 2025 May 26;26(11):5093. doi: 10.3390/ijms26115093.
芦丁通过AMPK/SREBP1通路改善糖尿病性非酒精性脂肪性肝病的脂质代谢功能障碍。
Phytomedicine. 2024 Apr;126:155437. doi: 10.1016/j.phymed.2024.155437. Epub 2024 Feb 9.
4
Nobiletin Ameliorates Hepatic Lipid Deposition, Oxidative Stress, and Inflammation by Mechanisms That Involve the Nrf2/NF-κB Axis in Nonalcoholic Fatty Liver Disease.川陈皮素通过涉及 Nrf2/NF-κB 轴的机制改善非酒精性脂肪性肝病中的肝脂质沉积、氧化应激和炎症。
J Agric Food Chem. 2023 Dec 20;71(50):20105-20117. doi: 10.1021/acs.jafc.3c06498. Epub 2023 Dec 10.
5
The Roles of NFR2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases.NFR2 调节的氧化应激和线粒体质量控制在慢性肝病中的作用
Antioxidants (Basel). 2023 Oct 29;12(11):1928. doi: 10.3390/antiox12111928.
6
Caveolin-1 is critical for hepatic iron storage capacity in the development of nonalcoholic fatty liver disease.窖蛋白-1 在非酒精性脂肪性肝病发展过程中对肝脏铁储存能力至关重要。
Mil Med Res. 2023 Nov 8;10(1):53. doi: 10.1186/s40779-023-00487-3.
7
Implications of the evolving knowledge of the genetic architecture of MASLD.代谢相关脂肪性肝病(MASLD)遗传结构不断演变的知识所带来的影响。
Nat Rev Gastroenterol Hepatol. 2024 Jan;21(1):5-6. doi: 10.1038/s41575-023-00866-0.
8
Dietary and lifestyle oxidative balance scores are independently and jointly associated with nonalcoholic fatty liver disease: a 20 years nationally representative cross-sectional study.饮食和生活方式氧化平衡评分与非酒精性脂肪性肝病独立且共同相关:一项为期20年的全国代表性横断面研究。
Front Nutr. 2023 Oct 18;10:1276940. doi: 10.3389/fnut.2023.1276940. eCollection 2023.
9
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease.SIRT5 rs12216101T>G 变异与非酒精性脂肪性肝病患者的肝损伤和线粒体功能障碍有关。
J Hepatol. 2024 Jan;80(1):10-19. doi: 10.1016/j.jhep.2023.09.020. Epub 2023 Oct 25.
10
Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential.非酒精性脂肪性肝病中的硫氧还蛋白/谷氧还蛋白系统与肠道微生物群:相互作用、机制及治疗潜力
Antioxidants (Basel). 2023 Aug 28;12(9):1680. doi: 10.3390/antiox12091680.